The FDA-approved, lipid-lowering medication gemfibrozil may prevent the progression of juvenile Batten disease, according to researchers at RUSH. Results from the study were recently published in The Journal of Neuroscience.
Mar 17, 2023
0
29
Imagine trying to navigate an unfamiliar city but you've lost your smartphone. You don't have a map. And the street signs are in a foreign language. This is how neuroscientists feel about studying the brain.
Mar 17, 2023
0
8
In virtually all persons with amyotrophic lateral sclerosis (ALS) and in up to half of all cases of Alzheimer's disease (AD) and frontotemporal dementia, a protein called TDP-43 is lost from its normal location in the nucleus ...
Mar 16, 2023
0
80
New research by the Human Brain Project has found that in the brains of patients with epilepsy, changes in large scale neuronal activations can be detected in the brain's resting state activity, even when no seizure is ongoing. ...
Mar 15, 2023
0
55
Routine tasks that require working memory, like baking, involve remembering both some general rules (e.g. read the oven temperature and time from the recipe and then set them on the oven) and some specific content for each ...
Mar 15, 2023
0
67
For a functioning brain to develop from its embryonic beginnings, so much has to happen and go exactly right with exquisite precision, according to a just-so sequence in space and time. It's like starting with a brick that ...
Mar 15, 2023
0
3
University of Malta researchers have discovered a potential new drug target for amyotrophic lateral sclerosis (ALS), according to a new study published in the Neurobiology of Aging journal.
Mar 14, 2023
0
3
A promising therapy for a range of brain diseases involves antisense oligonucleotides (ASOs)—specialized molecules that can modulate RNA and alter protein production—directly injected into the cerebrospinal fluid, in ...
Mar 13, 2023
0
575
Alzheimer's disease is the most common neurodegenerative disease in people over 65 and affects more than 50 million people worldwide—a number that is expected to double in 20 years. University of Minnesota scientists are ...
Mar 8, 2023
0
2
Scientific evidence shows how the cognitive decline in Alzheimer's disease (AD) is caused by the buildup of amyloid beta proteins, which promote synaptic malfunction. One of the neuropathological features in the brains of ...
Mar 8, 2023
0
39
